10 results
10-K
2023 FY
MREO
Mereo Biopharma Group Plc
27 Mar 24
Annual report
5:20pm
not demonstrated the sustainability of our business model of acquiring and developing product candidates from, and becoming a partner of choice
F-4/A
MREO
Mereo Biopharma Group Plc
15 Mar 19
Registration of securities (foreign) (amended)
5:08pm
. Additionally, although Mereo has acquired product candidates from two large pharmaceutical companies, it has not demonstrated the sustainability of its business
20-F
2018 FY
MREO
Mereo Biopharma Group Plc
29 Apr 19
Annual report (foreign)
4:59pm
product candidates from two large pharmaceutical companies, it has not demonstrated the sustainability of its business model of acquiring and developing
F-1/A
MREO
Mereo Biopharma Group Plc
6 Mar 20
Registration statement (foreign) (amended)
5:32pm
have not demonstrated the sustainability of our business model of acquiring and developing product candidates from, and becoming a partner of choice
424B3
kc3xljpixo93vgo
20 Mar 19
Prospectus supplement
4:58pm
F-4
sgsmqgy7ucf ttzce8x
25 Jan 19
Registration of securities (foreign)
12:00am
F-1/A
hh29i40
12 Mar 20
Registration statement (foreign) (amended)
5:15pm
- Prev
- 1
- Next